Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-02-24 @ 8:50 AM
Study NCT ID:
NCT00036751
Status:
COMPLETED
Last Update Posted:
2013-01-24
First Post:
2002-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: